Image source

Organigram (OGI) declined 11.6% during week ending June 20th and, while there wasn’t a single headline-grabbing event the combination of broader market jitters, leadership changes, and recent gains made OGI vulnerable to a pullback:

1. Sector sentiment: The cannabis industry as a whole faced pressure last week, with several major players (see here and here) experiencing sharp declines. This kind of sector-wide movement often drags down peer stocks like OGI.
2. Profit-taking and volatility: After a strong run earlier in the quarter, some investors may have locked in gains, especially with OGI’s stock having climbed from $1.03 at the end of March to $1.46 by mid-June and
3. Leadership transition: Organigram’s CEO announced plans to retire in late May, which may have introduced some uncertainty about the company’s strategic direction.

About Organigram Global

Organigram Global Inc. engages in the production and sale of:

• medical cannabis products,
• adult use recreational cannabis,
• cannabis-derived products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates in Canada and 
• in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers.

Stock Price Forecast and Analyst Ratings

There is currently no analyst price target forecast available for Organigram Global.

More By This Author:

Cannabis Stock Canopy Growth (CGC) Declined 16% W/e June 20th - Here's Why
Aurora Cannabis Fell 20% On Wednesday - Here's Why
Micron Technology Continues To Surge: Up Another 22% Already In June - Here's Why